{"id":"NCT00282347","sponsor":"Genentech, Inc.","briefTitle":"A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis","officialTitle":"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With ISN/RPS Class III or IV Lupus Nephritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2009-01","completion":"2013-01","firstPosted":"2006-01-26","resultsPosted":"2010-02-23","lastUpdate":"2015-01-15"},"enrollment":144,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Lupus Nephritis"],"interventions":[{"type":"DRUG","name":"Rituximab","otherNames":["Rituxan","MabThera","Zytux"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Mycophenolate mofetil","otherNames":["CellCept"]},{"type":"DRUG","name":"Methylprednisolone","otherNames":[]},{"type":"DRUG","name":"Diphenhydramine","otherNames":[]},{"type":"DRUG","name":"Acetaminophen","otherNames":[]},{"type":"DRUG","name":"Prednisone","otherNames":[]}],"arms":[{"label":"Rituximab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This was a Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of rituximab in combination with mycophenolate mofetil (MMF) compared with placebo in combination with MMF in subjects diagnosed with International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV lupus nephritis.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved a Complete Renal Response (CRR), a Partial Renal Response (PRR), or no Renal Response (NRR) at Week 52","timeFrame":"Week 52","effectByArm":[{"arm":"Rituximab","deltaMin":26.4,"sd":null},{"arm":"Placebo","deltaMin":30.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.5538"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":27},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30089664","26867033","22231479"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":73},"commonTop":["Diarrhoea","Upper Respiratory Tract Infection","Headache","Nausea","Urinary Tract Infection"]}}